Karačić Andrija, Renko Ira, Krznarić Željko, Klobučar Sanja, Liberati Pršo Ana-Marija
The Gut Microbiome Center (CCM), 10110 Zagreb, Croatia.
Faculty of Food Technology and Biotechnology, University of Zagreb, 10000 Zagreb, Croatia.
Biomedicines. 2024 Oct 4;12(10):2263. doi: 10.3390/biomedicines12102263.
: The phyla Firmicutes and Bacteroidetes are the main constituents of the gut microbiota. An imbalance in the gut microbiota is a sign of dysbiosis, and the Firmicutes-to-Bacteroidetes ratio has been proposed to be a marker of it, especially in the context of obesity. Since Croatia is the country with one of the highest obesity rates in Europe, a pilot observational study was conducted. The aim of the study was to investigate the validity of this potential biomarker in a methodological study using sample processing, DNA sequence analysis and characterization of recruited participants, including various health factors. : A study involving Croatian population was conducted. Participants age, body weight, gender, health history and lifestyle factors were recorded. Gut microbiota composition was analyzed using 16S rRNA sequencing. The F/B ratio was calculated and evaluated in the context of health factors. Statistical analysis was performed to detect the possible association of F/B ratio and excess body weight (kg) and possible impact of certain lifestyle factors. : No association between the F/B ratio and excess body weight (kg) was found. Excess body weight was significantly associated with higher age, male gender, and history of appendectomy. No significant health predictors of the F/B ratio were found, but weight gain was positively associated with a higher average F/B ratio. : Although this study could not confirm the predictive value of the F/B ratio or any other phyla-related biomarker for excess body weight in the study population, it demonstrated interesting insights into the obesity-associated gut microbiota.
Front Cell Infect Microbiol. 2025-8-11
BMC Microbiol. 2025-8-20
J Microbiol Biotechnol. 2025-4-24
Diabetes Metab Syndr Obes. 2023-11-20
PLoS Biol. 2023-3
Diagnostics (Basel). 2022-7-19
Front Endocrinol (Lausanne). 2022
Biomed Pharmacother. 2022-3
Front Cell Infect Microbiol. 2021
Annu Rev Public Health. 2021-4-1